HMN trades 19.2% above Wall Street's consensus target of $41.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HMN achieves its forward estimates and maintains a stable P/E multiple of 11.4x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, Horace Mann Educators Corporation (HMN) has a Wall Street consensus price target of $41.67, based on estimates from 9 covering analysts. With the stock currently trading at $51.60, this represents a potential downside of -19.2%. The company has a market capitalization of $2.08B.
Analyst price targets range from a low of $35.00 to a high of $48.00, representing a 31% spread in expectations. The median target of $42.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, HMN trades at a trailing P/E of 13.2x and forward P/E of 11.4x. The forward PEG ratio of 2.92 reflects a premium valuation. Analysts expect EPS to grow +13.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $60.97, with bear and bull scenarios of $38.41 and $80.33 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AFLAflac Incorporated | $61.2B | $120.15 | $115.17 | -4.1% | Hold | 17.0x | 32 |
CNOCNO Financial Group, Inc. | $4.9B | $52.52 | $48.00 | -8.6% | Hold | 11.8x | 17 |
GLGlobe Life Inc. | $13.9B | $179.31 | $174.50 | -2.7% | Hold | 11.5x | 28 |
FGF&G Annuities & Life, Inc. | $3.7B | $27.02 | $31.00 | +14.7% | Hold | 6.9x | 9 |
METMetLife, Inc. | $56.0B | $85.95 | $94.86 | +10.4% | Buy | 8.7x | 33 |
PRUPrudential Financial, Inc. | $37.7B | $108.25 | $98.71 | -8.8% | Hold | 7.9x | 37 |
LNCLincoln National Corporation | $7.0B | $36.72 | $41.00 | +11.7% | Hold | 4.8x | 28 |
UNMUnum Group | $14.6B | $90.12 | $98.33 | +9.1% | Hold | 10.3x | 30 |
PFGPrincipal Financial Group, Inc. | $23.3B | $107.75 | $102.43 | -4.9% | Hold | 11.5x | 25 |
VOYAVoya Financial, Inc. | $8.5B | $91.14 | $95.71 | +5.0% | Buy | 9.6x | 26 |
Quick answers to the most common questions about buying HMN stock.
HMN's consensus price target is $41.67, -19.2% below the current price of $51.6. The 9 analysts tracking HMN see downside risk at present valuations.
HMN has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $41.67 implies -19.2% downside from current levels.
With a forward P/E of 11.3985x, HMN trades at a relatively low valuation. The consensus target of $41.67 implies -19.2% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $48 for HMN, while the most conservative target is $35. The consensus of $41.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $80 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HMN is moderately covered, with 9 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 3 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HMN stock forecast based on 9 Wall Street analysts shows a consensus price target of $41.67, with estimates ranging from $35 (bear case) to $48 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $61, with bear/bull scenarios of $38/$80.
Our quantitative valuation model calculates HMN's fair value at $61 (base case), with a bear case of $38 and bull case of $80. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
HMN trades at a forward P/E ratio of 11.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on HMN, with 0 Sell ratings and a price target of $41.67 (-19.2% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HMN analyst price targets range from $35 to $48, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $41.67 consensus represents the middle ground. Our model's $38-$80 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.